Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 73.40
+2.30 (3.23%)
At close: Aug 20, 2025, 1:25 PM CST
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.71 billion as of August 20, 2025.
Market Cap
3.71B
Enterprise Value
3.57B
Revenue
130.70M
Ranking
n/a
PE Ratio
203.89
Stock Price
73.40
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.71B, an increase of 166.41%. That is a compound annual growth rate of 150.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 3.71B | 124.02% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 30.60T |
| Hon Hai Precision Industry | 2,875.28B |
| MediaTek | 2,183.59B |
| Delta Electronics | 1,781.91B |
| Fubon Financial Holding | 1,213.52B |
| Chunghwa Telecom | 1,047.26B |
| Quanta Computer | 1,042.65B |
| Cathay Financial Holding | 949.10B |